News Hub | News Direct

All Industries


Article thumbnail News Release

HNO International Converting Wasted Flared Gas Into Energy for Bitcoin Mining, Data Center Infrastructure, and Hydrogen Production Through Newly Launched EcoFlare Power Division

HNO International

HNO International, Inc. (OTC: HNOI), a leader in hydrogen-based clean energy solutions, announces the launch of EcoFlare Power, a dedicated division focused on harnessing wasted natural gas from flaring to generate reliable power to produce hydrogen and electricity for high-performance data centers and Bitcoin mining. Each year, billions of cubic feet of natural gas are lost through flaring, contributing to environmental degradation and the waste of a valuable energy resource. EcoFlare Power directly addresses this challenge by capturing flared gas and repurposing it into sustainable power, while also lowering the CO2 emissions of the flared gas. Thus, transforming an environmental liability into a powerful asset for the digital economy. For a summary of the EcoFlare Power Division, please review the video at this link. "The launch of EcoFlare Power represents a pivotal step in HNO International’s mission to drive the clean energy transition," said Donald Owens, Chairman and CEO of HNO International. "By capturing wasted flared gas and converting it into electricity and hydrogen, we are not only addressing a critical environmental issue but also creating a scalable energy solution for the industries that will shape the future." Sustainable Energy for the Future EcoFlare Power is designed to support the growing energy demands of data center infrastructure, AI-driven workloads, and blockchain technology, offering: • Conversion of flared gas into scalable, clean energy solutions • Hydrogen production for backup power generation, industrial and transportation applications • Environmental impact reduction by lowering carbon emissions from wasted flaring • Decentralized power solutions, increasing energy independence and efficiency Positioned for Growth in a Trillion-Dollar Market With increasing global regulations against flaring and rising demand for hydrogen and decentralized power, EcoFlare Power is set to be a key player in the future energy economy. The initiative aligns with HNO International’s broader strategy of hydrogen innovation, reinforcing its commitment to delivering cutting-edge, renewable energy solutions on a global scale. For more information and media inquiries, please contact: HNO International, Inc. press@hnointl.com HNO International (OTC: HNOI) specializes in the design, integration, and development of green hydrogen-based energy technologies. With over 15 years of experience, HNOI is at the forefront of the renewable energy transition, pioneering solutions such as the Scalable Hydrogen Energy Platform (SHEP), the Compact Hydrogen Refueling System (CHRS) and the Mobile Hydrogen Refueling System (MHRS) to make hydrogen accessible for businesses and communities worldwide. This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov. Contact Details HNO International Donald Owens press@hnointl.com

February 26, 2025 08:00 AM Eastern Standard Time

Article thumbnail News Release

Sector Spotlight: 4 Stocks Riding the Gold Surge

SDRC GOLD PPTA IDR

Gold mining stocks are having a moment. In the early months of 2025, shares of gold miners have surged, outpacing even the price of gold itself. The VanEck Gold Miners ETF, a bellwether for the sector, is up 20% year-to-date, compared to gold’s 12% rise and the S&P 500’s modest 1.7% gain. This marks a significant shift from recent years, when miners often lagged behind the metal they produce. What’s driving this outperformance? For starters, gold itself is on a tear, hitting all-time highs as investors seek refuge from persistent inflation, geopolitical tensions, and market volatility. But beyond gold’s traditional role as a safe-haven asset, mining stocks offer something extra: leverage. When gold prices rise, miners’ profit margins expand, often leading to even greater returns for shareholders. Moreover, gold mining companies are no longer just about digging for gold. Many are embracing innovative technologies, sustainable practices, and strategic expansions—factors that enhance their growth potential and appeal to a broader range of investors. In this piece, we highlight four gold mining stocks that stand out in today’s market—each offering a unique opportunity to capitalize on gold’s strength and the sector’s potential. Sidney Resources Corporation (OTC: SDRC) Sidney Resources Corporation is an emerging mining and exploration company focused on unlocking the potential of precious metal resources in Idaho’s Warren Mining District. With a clear vision of innovation, sustainability, and value creation, Sidney Resources has been making moves to position itself for growth. Recent developments highlight the company’s progress and its potential to capitalize on the growing demand for precious metals and rare earth elements (REEs). In December 2024, SDRC achieved a significant milestone by securing over $8 million in funding. This capital injection is supporting the construction of a state-of-the-art milling and processing facility, set to break ground in Q2 2025. The facility is designed to increase processing capacity, improve efficiency, and uphold high environmental standards, enabling Sidney Resources to process more ore in-house and potentially boost revenue. More recently, SDRC announced they acquired the historic Silver Monarch property, a 40-acre site in the Warren District with a documented history of high-value ore production. Historical records show that the mine yielded up to 80 ounces per ton when gold was priced at just $19 per ounce. Modern XRF testing has confirmed the presence of gold, silver, platinum, and other valuable metals like iridium and palladium. The property also includes five distinct vein structures, with geological evidence suggesting untapped potential at depths beyond 2,000 feet. The momentum continued this month with the acquisition of Unity Gold Silver Mines Inc. assets. This transformative deal added 168 acres of private land, 1,477 acres of unpatented mineral claims, and access to high-value mine spoils and vein systems. Preliminary testing of the mine spoils indicates recoverable gold, silver, and platinum group metals (PGMs), with historical assays showing values as high as 14 ounces of gold and 35 ounces of silver per ton. The acquisition also integrates the Little Giant Mine, a contiguous vein system spanning 9,000 feet, enhancing operational synergy and exploration potential. Recent assay results from the Warren District further underscore the company’s potential. Analyses of 25,000 tons of ore revealed impressive concentrations of gold (10.2 oz/ton), silver (42.2 oz/ton), platinum (8.1 oz/ton), and rare earth elements (REEs). These results highlight the world-class potential of Sidney Resources’ holdings and demonstrate the company’s ability to leverage modern technology to unlock value from complex ore bodies. With a strong leadership team, a clear vision for sustainable mining practices, and a portfolio of high-potential properties, Sidney Resources Corporation (OTC: SDRC) is positioning itself to capitalize on the increasing demand for precious metals and rare earth elements. The combination of recent funding, acquisitions, and strong assay results suggests the company has the potential to grow its operations and deliver value to shareholders in the coming years. Barrick Gold Corporation (NYSE: GOLD) (TSX: ABX) Barrick Gold Corporation is a global mining powerhouse and a top-tier gold stock to watch. With a diversified portfolio of high-quality assets, including Nevada Gold Mines, Pueblo Viejo, and Kibali, Barrick has consistently demonstrated its ability to grow reserves and replace annual depletion at higher grades. In 2024, the company increased its attributable proven and probable gold reserves by 23%, adding 17.4 million ounces, largely due to the transformational Reko Diq copper-gold project. This marks the fourth consecutive year Barrick has replaced depletion at a higher grade, showcasing its operational excellence and focus on long-term value creation. Barrick’s copper reserves also saw a remarkable 224% year-on-year increase, driven by the Lumwana Super Pit Expansion and Reko Diq feasibility studies. These projects, alongside others like Fourmile and Pueblo Viejo Expansion, underscore Barrick’s commitment to organic growth and sustainability. With a disciplined reserve replacement strategy, a strong balance sheet, and a focus on high-grade deposits, Barrick is well-positioned to deliver multi-generational benefits to shareholders and host communities alike. For investors seeking exposure to a resilient and growth-oriented gold stock, Barrick Gold Corporation is one to keep an eye on. Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) Perpetua Resources is advancing the Stibnite Gold Project, one of the highest-grade open-pit gold deposits in the United States, located in central Idaho. The project stands out not only for its estimated 4.8 million ounces of gold reserves but also for its critical antimony reserves—the only identified domestic source of this mineral. With China cutting off global antimony exports in late 2024, the Stibnite Gold Project is poised to supply 35% of U.S. antimony demand in its first six years, bolstering national security and reducing reliance on foreign suppliers. The project has achieved significant milestones, including the Final Record of Decision from the U.S. Forest Service in January 2025, following an eight-year permitting process. This approval underscores Perpetua’s commitment to environmental restoration, including improving water quality, restoring fish habitats, and increasing wetland acres. The company’s ESG-focused approach, combined with its use of low-carbon energy, aligns with sustainable mining practices. Financially, the Stibnite Gold Project boasts robust economics, with an after-tax net present value (NPV) of $3.7 billion and an internal rate of return (IRR) exceeding 27%. With an expected gold price of $2,435 per ounce in the first four years, the project is set to become one of the lowest-cost gold operations in Tier 1 jurisdictions. Perpetua has also secured a procurement contract with Idaho Power, marking a key step toward construction, which is expected to begin in 2025. By combining gold production with critical mineral supply and environmental restoration, Perpetua Resources is uniquely positioned to deliver economic, environmental, and national security benefits, making it a standout in the gold mining sector. Idaho Strategic Resources (NYSE American: IDR) Idaho Strategic Resources is a unique gold producer with a rare twist: it also owns the largest rare earth elements (REE) land package in the U.S., making it a standout in the mining sector. In 2024, IDR delivered impressive results, including an 86.39% increase in revenue to $6.15 million and $376.44 million in Q3. Gold production rose by 45% to 2,892 ounces, driven by higher ore grades and operational efficiencies at its Golden Chest mine. What sets IDR apart is its dual focus on gold and REEs, positioning it to benefit from both the stability of gold and the booming demand for critical minerals. Its Lemhi Pass REE project has shown early promise, with sampling revealing high concentrations of neodymium (Nd), praseodymium (Pr), and dysprosium (Dy)—key elements for magnets used in electric vehicles and renewable energy technologies. These four elements alone accounted for up to 76% of total REEs in some samples, rivaling globally significant deposits like Mountain Pass (California) and Mt. Weld (Australia). This year, IDR is executing a large-scale trenching and drilling program at Lemhi Pass, spanning over 12,000 acres, to further define its REE resources. The company is also collaborating with national laboratories to develop tailored REE processing technologies, ensuring its projects are economically viable. Additionally, IDR secured a $430,000 grant for infrastructure upgrades and partnered with Radiant Industries to explore micronuclear reactors for mining operations, showcasing its innovative approach to sustainable energy solutions. With a disciplined growth strategy, a strong balance sheet, and a team capable of handling rapid expansion, IDR is well-positioned to capitalize on its dual gold and REE potential. For investors seeking exposure to both precious metals and the critical minerals boom, IDR is a compelling choice. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performances are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated SDRC by to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only; you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third-party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 Mark@razorpitch.com Company Website http://razorpitch.com

February 26, 2025 07:00 AM Eastern Standard Time

Article thumbnail News Release

CoorsTek Denver Metro Regional Science & Engineering Fair (DMRSEF) Returns to the University of Colorado Denver

CoorsTek

The CoorsTek Denver Metro Regional Science & Engineering Fair (DMRSEF) is back and set to take place on Friday, February 28, 2025, at the University of Colorado Denver. This annual event is a celebration of science, engineering, and innovation, bringing together students from grades 6-12 across eight Denver metro counties to showcase their original research. Last year's fair was a tremendous success, thanks in part to the incredible contributions of volunteers and judges. With over 150 projects recognized, the fair empowered 227 students from 34 schools to shine. This year, we aim to make the event even greater and continue to inspire the next generation of STEM leaders. CoorsTek invests in the Denver Metro Regional Science & Engineering Fair (DMRSEF) to empower the next generation of STEM professionals by fostering an enthusiasm for science and inquiry. The company believes in providing students with opportunities to engage with the STEM community, compete for awards, and gain valuable experience in presenting their research. By supporting the fair, CoorsTek aims to inspire young innovators and celebrate their achievements, ensuring they have the necessary resources to excel in their scientific endeavors. "As a company built on a foundation of scientific innovation, CoorsTek is committed to fostering the next generation of problem solvers," said Randel Mercer, Chief Technology Officer at CoorsTek. "Events like the Denver Metro Regional Science & Engineering Fair are crucial in nurturing curiosity, critical thinking, and a passion for discovery. We are proud to support these young minds as they push the boundaries of what’s possible." DMRSEF provides a unique opportunity for students to engage with the STEM community, compete for awards, and gain valuable experience in presenting their research. We invite everyone to join us in supporting these young innovators and celebrating their achievements. For more information about the event, please visit our website https://clas.ucdenver.edu/denversciencefair/ About CoorsTek CoorsTek is a privately-held leading global supplier of technical ceramics, serving a wide array of industries and markets – with the vision of making the world measurably better. The company is headquartered in Golden, Colorado, with approximately 5,000 employees worldwide. CoorsTek continues to make significant investments in developing advanced materials and processes for critical applications and is the partner of choice for companies worldwide, whose success requires the unique, high-performance properties of products manufactured from engineered ceramics and advanced materials. The company is committed to delivering outstanding value through operational excellence, research, development, and manufacturing capabilities and collaborative stakeholder relationships. Learn more at www.coorstek.com. Contact Details CoorsTek Ashley Clutter +1 303-648-1895 aclutter@coorstek.com Company Website https://www.coorstek.com

February 25, 2025 12:07 PM Mountain Standard Time

Article thumbnail News Release

Justin Sun and WLFI Co-Founder Headline Consensus HK 2025 as TRON DAO Showcases T3 FCU

TRON DAO

Geneva, Switzerland, February 25 2025 – TRON DAO made a significant impact at Consensus Hong Kong 2025 as a 5-Block Sponsor, delivering a series of high-impact events and discussions that highlighted its leadership in the blockchain industry. Key highlights include a panel featuring Justin Sun, Founder of TRON, alongside the co-founder of World Liberty Financial (WLFI), in-depth conversations on the evolution of the T3 Financial Crime Unit (T3 FCU). These initiatives reinforce TRON DAO’s commitment to driving innovation, collaborating with industry leaders, and shaping the future of decentralized finance. Setting the Stage for Consensus Hong Kong 2025 TRON DAO kicked off the week as the co-host of the Official Opening Party, welcoming over 400 approved attendees to an exclusive gathering that marked the start of Consensus Hong Kong 2025. At the party, Sun opened Consensus Hong Kong with a welcome toast, recognizing the CoinDesk team for their impact and congratulating them on a successful launch of the event. Justin Sun Panel Discussions with WLFI and T3 FCU Sun took the main stage at Consensus for a panel discussion titled “Unlocking DeFi for the Masses: A Conversation with WLFI and TRON.” Held on February 19th, this 45-minute panel session featured Sun alongside Zak Folkman, Co-Founder of World Liberty Financial, moderated by Sam Reynolds, Senior Reporter at CoinDesk. The discussion explored the strategic alignment between TRON and WLFI, highlighting their joint efforts to accelerate the global adoption of decentralized finance. The panel also examined TRON’s exceptional performance in 2024, including its revenue growth, leadership in stablecoin transactions, and advancements in the T3 Financial Crime Unit initiatives. Sun also participated in a second panel with industry leaders including Leonardo Real, Chief Compliance Officer at Tether, Chris Janczewski, Head of Global Investigations at TRM Labs, Arnold Lee, CEO/co-founder of Sphere and Anthony Yim, Co-founder of Artemis to discuss the global adoption of T3 FCU while addressing the importance of decentralization, security, and scalability. This discussion spotlighted the collective efforts of TRON, Tether, and TRM Labs in combating cryptocurrency-related financial crimes, resulting in over $126 million in criminal assets frozen to date. It further emphasized their shared commitment to expanding global reach while staying true to their foundational principles. Justin Sun CoinDesk Live Interview Following February 20th Sun made an appearance on CoinDesk Live for a 8-minute in-person video interview, streamed on CoinDesk’s Live Page. Hosting this interview was Ben Schiller, Managing Editor at CoinDesk and Jenn Sanasie, Executive Producer & Senior Anchor at CoinDesk. Key discussion points included TRON’s exponential growth, now supporting over 290 million user accounts and 2.5 million daily active addresses, generating over $2 billion in protocol revenue in the past year. TRON’s fast, low-cost, and scalable blockchain continues to lead in stablecoin transactions and on-chain security initiatives. Consensus HK 2025 brought together industry leaders, innovators, and allowed for the TRON DAO contributors to connect with community members in person. TRON played a key role in shaping these conversations, from insightful discussions on the future of DeFi to unveiling new initiatives that drive real-world adoption. The event reinforced the growing impact of blockchain technology and the importance of collaboration in building a more open and accessible financial system. With innovation at the forefront, the path toward a decentralized future continues to accelerate. About TRON DAO TRON DAO is a community-governed DAO dedicated to accelerating the decentralization of the internet via blockchain technology and dApps. Founded in September 2017 by H.E. Justin Sun, the TRON blockchain has experienced significant growth since its MainNet launch in May 2018. Until recently, TRON hosted the largest circulating supply of USD Tether (USDT) stablecoin, exceeding $60 billion. As of February 2025, the TRON blockchain has recorded over 290 million in total user accounts, more than 9.7 billion in total transactions, and over $20.5 billion in total value locked (TVL), based on TRONSCAN. TRONNetwork | TRONDAO | X | YouTube | Telegram | Discord | Reddit | GitHub | Medium | Forum Media Contact Yeweon Park press@tron.network Contact Details Yeweon Park press@tron.network Company Website https://trondao.org/

February 25, 2025 09:57 AM Eastern Standard Time

Image
Article thumbnail News Release

Tickets On Sale Today For 2025 Monterey Motorsports Festival During Car Week

Monterey Motorsports Festival

With an increasing number of enthusiasts heading to Monterey, CA in mid-August for the world famous Car Week, there’s been a distinct lack of affordable, accessible, organized events for gearheads. One notable exception is Monterey Motorsports Festival, which is gearing up for its third annual celebration of all things motorized. Taking place on Saturday August 16, 2025 at the 22-acre Monterey County Fairgrounds – located just 3 miles from Cannery Row – Monterey Motorsports Festival is priced to be accessible to everyone. Early Bird tickets are available today from montereymotorsportsfestival.com at just $89. This special offer is available for a limited time, so don’t delay and buy today! The 2025 Monterey Motorsports Festival offers a cornucopia of machines and activities for the entire family. And children under 12 enter free! Keeping with its philosophy of One Culture. All Cars, visitors will be able to view and enjoy highly curated displays featuring the best from the following categories: Hypercars & Supercars American Muscle Lowriders Race Cars Overland & 4-Wheelers JDM European EV Motorcycle Heavy Machinery While exotic sports cars are the trademark of Car Week, Monterey Motorsports Festival celebrates all genres and brands. So, visitors will be able to marvel at the fastest and most expensive hypercars while also viewing a wide array of vehicles that make the car hobby so enjoyable. In addition to the mainstream car segments, visitors can see a variety of two-wheeled transport and some of the latest heavy plant machinery for contrast and entertainment. MORE THAN MOTORING Running from 2PM-10PM on Saturday August 16, the Monterey Motorsports Festival will ensure your eyes, stomach and ears are satisfied by everything from a wide selection of catering options to themed cocktails. And for the kids, there’s the Family Fun Zone to check out and burn off some energy. As darkness falls, the famous stage where Jimi Hendrix set fire to his guitar will again reverberate with musical energy as The Outlaw Mariachi ( @theoutlawmariachi ) take the stage with their own brand of Mariachi-style rock, followed by the evening’s headliners Don’t Stop Believing ( @DSBband ), rated as the best Journey cover band in the world. TICKET OPTIONS When ordering the Early Bird tickets available today from montereymotorsportsfestival.com priced at just $89, visitors can choose to elevate their experience by adding the Vino & Vibes options as well as VIP Access. Both can be selected to ensure nothing is missed during the event. Vino & Vibes will provide access to the event’s wine garden with a selection of fine wines, while the VIP area will provide a place to relax, eat, drink and hang out with friends. Both elevated options are available in limited numbers and may sell-out quickly. *Please note: Monterey Motorsports Festival is a private, ticketed event. Tickets will remain available while supplies last. EDITOR’S NOTE A video from Monterey Motorsports Festival 2024 is available to view and share here: youtube.com/watch?v=d3Gm9xiqHbU Media wishing to attend the show can request passes using the Media Contact below. ABOUT MONTEREY MOTORSPORTS FESTIVAL The Monterey Motorsports Festival is the premier Saturday event during car week. It offers an elevated and curated experience, which is affordable for attendees, families, and automotive enthusiasts. This is the only event open to the general public on Saturday night, showcasing automotive unveilings, classic cars, supercars, hypercars, off-road vehicles, motorcycles, live entertainment, curated food and more. montereymotorsportsfestival.com Contact Details The ID Agency Greg Emmerson greg@theidagency.com

February 25, 2025 06:07 AM Pacific Standard Time

Image
Article thumbnail News Release

Argo Living Soils (CSE: ARGO) (OTC: ARLSF): Positioned for Growth in a $31.35 Billion Industry

ARLSF/ARGO

The global sustainable agriculture market is on a rapid growth trajectory, fueled by increasing environmental awareness, regulatory backing, and a surging demand for organic products. Valued at $13.32 billion in 2022, the market is projected to more than double, reaching $31.35 billion by 2031, with a compound annual growth rate (CAGR) of 10.17%. This expansion is driven by critical factors such as climate change adaptation, global food security concerns, and the integration of circular economy principles into farming. As consumers and industries alike shift toward more eco-friendly and regenerative agricultural methods, companies leading in sustainable solutions are well-positioned to capitalize on this momentum. Argo Living Soils Corp. (CSE: ARGO) (OTC: ARLSF) is making strides in the sustainable agriculture sector. The company focuses on organic soil amendments, biofertilizers, and solutions that support more sustainable farming practices. With a growing range of eco-friendly products, expanding partnerships, and a focus on reducing chemical use in agriculture, Argo is positioning itself to meet the rising demand for sustainable agricultural solutions Innovating for a Sustainable Future Argo Living Soils is making waves in the sustainable agriculture sector, offering investors a unique opportunity to participate in a rapidly growing market. With a focus on organic soil amendments, biofertilizers, and eco-friendly farming solutions, Argo is well-positioned to capitalize on the increasing global demand for sustainable agricultural practices. The company’s recent strategic moves, including a groundbreaking partnership for biomass-to-graphene development, its entry into the green concrete market, and its application for an OTCQB listing, underscore its commitment to innovation, growth, and environmental stewardship. An Emerging Player in the Sustainable Agriculture Sector Argo Living Soils specializes in producing and developing organic products such as living soils, biofertilizers, and compost extracts tailored for high-value crops. The company’s mission is to create a brand synonymous with environmentally friendly farming solutions. Over the past month, Argo’s stock has surged by an impressive 281%, reflecting growing investor confidence in its business model and market potential. The company’s innovative approach to soil health addresses a critical need in modern agriculture. By reducing reliance on chemical fertilizers and pesticides, Argo’s products not only enhance crop yields but also promote environmental sustainability. This aligns with global trends, as governments, businesses, and consumers increasingly prioritize eco-friendly practices. OTCQB Listing: A Major Milestone On February 24, 2025, Argo announced that it has begun the process of listing its common stock on the OTCQB Venture Market, operated by OTC Markets Group. This move is expected to significantly enhance the company’s visibility and liquidity, providing greater access to its shares for a broader range of investors. Robert Intile, Argo’s CEO, emphasized the importance of this step, stating, “Listing on the OTCQB is an important step in our company’s growth. We believe that this listing will increase our visibility within the investment community, provide greater access to our shares for a broader range of investors, and enhance liquidity.” The OTCQB is a premier marketplace for developing companies, offering a cost-effective and efficient way to access the U.S. capital markets. To qualify, companies must meet stringent requirements, including current financial reporting, annual verification, and management certification. Argo’s application demonstrates its commitment to transparency and growth, further solidifying its appeal to investors. Strategic Partnerships and Expansion In October 2024, Argo entered into a research and development agreement with Connective Global to develop organic composted fertilizers and biomass-to-biochar soil additives. This collaboration aims to improve soil health while reducing carbon footprints, further solidifying Argo’s position as a leader in sustainable agriculture. More recently, Argo announced a memorandum of understanding (MOU) with PT. Aplikasi Grafena Industri & Consulting (AGIC) in Indonesia. This partnership focuses on building a commercial graphene R&D manufacturing facility for agricultural and industrial applications. Graphene, a revolutionary material known for its strength, conductivity, and versatility, has the potential to transform industries ranging from agriculture to construction. Robert Intile expressed enthusiasm about the partnership, stating, “We are excited to partner with AGIC, an innovative company that has created a low-cost way of producing high-quality graphene. Their patented technology can convert waste biomass into valuable graphene, which may revolutionize farming and industrial applications.” Entry into the Green Concrete Market Argo’s strategic vision extends beyond agriculture. In February 2025, the company announced plans to incorporate a new subsidiary, Argo Green Concrete Solutions Inc., in Nevada, USA. This venture will focus on developing environmentally friendly concrete solutions using bio-graphene derived from organic sources. The green concrete market represents a significant opportunity for Argo, as the construction industry seeks sustainable alternatives to traditional materials. Argo’s bio-graphene concrete is expected to be twice as strong and four times more water-resistant than conventional options, with the added benefit of reducing CO2 emissions. Financial Strength and Investor Confidence Argo’s recent financial developments further underscore its growth trajectory. The company successfully closed the final tranche of its non-brokered private placement, raising a total of $302,975. Additionally, Argo received $710,600 CDN from the exercise of warrants since February 1, 2025. These funds will support the company’s R&D efforts, market expansion, and strategic initiatives. Competitive Advantages and Future Outlook Argo’s commitment to innovation, strategic partnerships, and sustainable practices sets it apart from competitors. The company’s focus on R&D has led to groundbreaking advancements in soil health and green construction materials. Its leadership team, bolstered by recent appointments with expertise in biochar and Southeast Asian agriculture, is well-equipped to drive growth in emerging markets. As global demand for sustainable solutions continues to rise, Argo is poised to capitalize on these trends. Its partnerships with AGIC and Connective Global, coupled with its entry into the green concrete market and its OTCQB listing application, position the company for long-term success. Argo Living Soils Corp. (CSE: ARGO) (OTC: ARLSF) is expanding its footprint in sustainable agriculture with organic soil solutions, biofertilizers, and eco-friendly innovations. With strategic moves into graphene, green concrete, and capital markets, the company is positioned for long-term growth while advancing environmentally conscious solutions. As global demand rises, Argo remains a key player to watch. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Awareness Consulting to assist in the production and distribution of content related to ARLSF. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 mark@razorpitch.com

February 25, 2025 07:00 AM Eastern Standard Time

Article thumbnail News Release

Riding the Antimony Wave: 4 Stocks to Watch as Prices Hit Record Highs

MILIF, PPTA, UAMY, NVA

Antimony, a critical but often overlooked metal, has surged to a record $51,000 per ton, driven by tightening Chinese export controls and escalating global demand. Essential for military ammunition, missile systems, flame retardants, and advanced electronics, antimony plays a pivotal role in both national defense and modern industry. Yet, the global supply chain for this vital mineral is in crisis. With China and Russia controlling nearly 100% of global production, NATO and Western nations are dangerously exposed to supply disruptions. The war in Ukraine has further strained resources, depleting stockpiles and underscoring the West’s reliance on foreign suppliers. Without a stable antimony supply, efforts to ramp up military production and sustain industrial output face serious risks. For investors, this crisis has created a unique opportunity. Western-backed mining projects are now at the forefront of securing alternative antimony sources, with companies like Perpetua Resources (NASDAQ: PPTA), United States Antimony Corporation (NYSE: UAMY), Nevada Exploration (NASDAQ: NVA), and Military Metals Corp. (OTCQB: MILIF) leading the charge. As governments and industries race to secure supply, these firms are positioned to benefit from rising prices and increasing importance. Let’s take a closer look. Military Metals Corp.: As the global antimony supply crisis deepens, Military Metals Corp. (CSE: MILI) (OTCQB: MILIF) is emerging as a key player in the global antimony supply race, leveraging a portfolio of high-potential projects across North America and Europe to address the critical mineral shortage. With a portfolio of high-potential antimony-gold projects across North America and Europe, the company is strategically positioned to capitalize on soaring antimony prices, which recently hit a record $51,500 per tonne. Military Metals’ flagship Trojárová Antimony-Gold Project in Slovakia is a standout asset. Located just three kilometers from the historic Pezinok mine—once Europe’s largest antimony producer—Trojárová benefits from rich mining history and extensive historical data. The project was the focus of 63 drill holes totaling 14,300 meters and 1.7 kilometers of underground development in the 1980s, culminating in a historical resource estimate. The company is currently digitizing and georeferencing this data to build a 3D deposit model, paving the way for a NI 43-101 compliant resource estimate. As CEO Scott Eldridge noted, “We look forward to unlocking value as we examine the brownfield benefits of the property." With Slovakia’s legacy as a high-grade antimony producer, Trojárová represents a significant opportunity to revive a once-thriving mining region. In North America, Military Metals is advancing two additional projects: the West Gore Antimony-Gold Project in Nova Scotia and the Last Chance Antimony-Gold Project in Nevada. West Gore, a historically significant producer that contributed to the Allied war effort during World War I, recently expanded its land position by 388 hectares, consolidating the mineralized system for future exploration. Between 1914 and 1917, West Gore produced 7,000 tons of antimony concentrate, grading 46% antimony, alongside nearly 6,900 ounces of gold. The company plans to launch exploration programs at West Gore in Q2-Q3 2025, aiming to unlock the property’s full potential. Meanwhile, Last Chance, located just 18 kilometers west of Kinross’s Round Mountain gold mine in Nevada, offers modern exploration potential in a mining-friendly jurisdiction. The property has a rich history of antimony production dating back to 1880, with limited production supporting U.S. defense efforts until the 1960s. Military Metals completed its acquisition of Last Chance in February 2025 and has already conducted an initial field visit. CEO Scott Eldridge highlighted the property’s potential, stating, “We were very impressed by its past and future.” With antimony prices hitting new highs, Last Chance represents a compelling opportunity to unlock value through modern exploration techniques. Military Metals is poised for an active year, with plans to advance exploration across its portfolio. The company is prioritizing the Trojárová project, where it aims to complete a NI 43-101 resource estimate and initiate a preliminary economic assessment. Additionally, exploration programs at West Gore and Last Chance are expected to commence in Q2-Q3 2025, further solidifying the company’s position as an emerging player in the antimony sector. As one of the few publicly traded companies focused on antimony, Military Metals offers investors a unique opportunity to gain exposure to a strategically important resource with explosive demand and limited supply. With its diversified portfolio, experienced management team, and strategic projects in mining-friendly jurisdictions, the company is well-positioned to benefit from the global antimony supply crisis. Perpetua Resources Corp.: Perpetua Resources Corp. (Nasdaq: PPTA) is at the forefront of addressing the West’s critical antimony supply gap through its Stibnite Gold Project in Idaho. This ambitious project is not only one of the highest-grade open-pit gold deposits in the U.S. but also home to the only domestically mined source of antimony—a mineral deemed critical for national defense, energy storage, and advanced technology. With an estimated 148 million pounds of antimony reserves, the Stibnite Gold Project is expected to supply 35% of U.S. antimony demand in its first six years of operation, significantly reducing reliance on foreign suppliers like China and Russia. Antimony trisulfide from Stibnite is the only known domestic source capable of meeting U.S. defense needs for ammunition, missile systems, and other military applications. Perpetua’s project has already garnered significant government support, including a $59.2 million Defense Production Act Title III funding award to advance construction readiness and permitting. Perpetua’s vision extends beyond resource extraction; the Stibnite Gold Project is designed to restore an abandoned mining site, addressing decades of environmental damage. The company’s approved plan includes removing legacy waste to improve water quality, restoring river habitats, and reopening fish passages blocked for over 80 years. This commitment to environmental, social, and governance (ESG) principles has earned Perpetua widespread community and regulatory support, including a Final Record of Decision from the U.S. Forest Service after an eight-year permitting process. Economically, the project is a powerhouse. It has an estimated 4.8 million ounces of gold reserves and plans for an annual production of 300,000 ounces over a 15-year mine life. The Stibnite Gold Project is projected to generate over $3.7 billion in after-tax net present value (NPV) at current spot prices. The antimony by-product, priced at $21 per pound, enhances the project’s economics, with all-in sustaining costs (AISC) for gold projected at just $435 per ounce in the first four years of production. Furthermore, Perpetua is advancing partnerships to strengthen the domestic antimony supply chain. The company has collaborated with U.S. Antimony Corporation (NYSE: UAMY) to explore processing options for antimony concentrate, ensuring a fully American supply chain. Additionally, a procurement agreement with Idaho Power guarantees that the project will be powered by one of the lowest-carbon energy grids in the nation, aligning with Perpetua’s sustainability goals. United States Antimony Corp.: United States Antimony Corp. (NYSE: UAMY) is taking bold steps to diversify North America’s antimony supply chain, leveraging its mines and processing facilities to reduce reliance on foreign sources. The company produces essential antimony products, including antimony oxide, metal, and trisulfide, which are vital for industries such as defense, manufacturing, and energy storage. Recently, USAC relocated its corporate headquarters to Dallas, Texas, enhancing operational efficiency and exploring new mining opportunities. This move aligns with the company’s focus on expanding its footprint in North America. A key development is USAC’s exclusive option agreement to acquire 120 antimony mining claims in Alaska, covering approximately 17,900 acres with significant mineral potential. Supported by historic exploration data, this acquisition positions USAC to bolster domestic production capabilities and contribute to national security. Executive Vice President Joe Bardswich emphasized the importance of the deal, stating, “This agreement provides us with a unique opportunity to strengthen our ownership position in antimony deposits, which are critical to our nation’s security needs.” In Mexico, USAC is revitalizing its Madero smelter, with plans to process 100 tons of antimony ore per month. The refurbishment, including repairs to furnaces and air control systems, aims to improve efficiency and meet rising domestic demand. John Gustavsen, President of the Antimony Division highlighted the urgency of these efforts, noting, “Worldwide antimony prices continue to reach all-time highs, and we are working quickly to meet our nation’s growing demand.” USAC has also strengthened its leadership team with the appointment of two new vice presidents. Rodney Blakestad, Vice President of the Mining Division, brings over 45 years of experience in mineral exploration and development, while Leo Jackson, Vice President of the Mexican Antimony Division, offers decades of expertise in operations management and supply chain logistics. These appointments underscore USAC’s commitment to scaling its operations and optimizing production. As global demand for antimony continues to rise, USAC’s proactive measures—from expanding its mining portfolio to upgrading its processing facilities—highlight its potential as a key player in securing a reliable supply of this strategically important resource. By addressing vulnerabilities in the current supply chain, USAC is well-positioned to deliver value to investors while contributing to national security and industrial resilience. Nova Minerals Limited: Nova Minerals Limited (NASDAQ: NVA) is positioning itself as a key contender in the race to secure critical antimony supplies through its flagship Estelle Critical Minerals Project in Alaska. Located in the prolific Tintina Gold Belt, the Estelle Project spans 514 square km and hosts multiple high-grade antimony prospects, including the standout Stibium and Styx targets. With China controlling over 50% of global antimony production and recently banning exports to the U.S., Nova’s focus on domestic antimony development couldn’t be more timely. The Stibium prospect has emerged as a cornerstone of Nova’s antimony strategy. Recent exploration results have revealed an 800 m x 400 m high-grade antimony zone, with rock samples grading up to 56.7% antimony and soil samples showing concentrations as high as 2.8% antimony. These results confirm Stibium as a drill-ready target for 2025, with the potential to become a significant source of domestically mined antimony. Nova’s CEO, Christopher Gerteisen, highlighted the importance of the prospect, stating, “Defining an antimony resource at Stibium and advancing toward production is a top priority for the company.” Nova’s exploration success extends beyond Stibium. At the Styx prospect, rock samples have returned grades of up to 54.1% antimony, with a main vein occurrence measuring 50% stibnite (antimony sulfide). These discoveries underscore the Estelle Project’s potential to become a major supplier of antimony, which is essential for military ammunition, missile systems, flame retardants, and advanced electronics. To accelerate its antimony development, Nova is actively pursuing U.S. government support. As a member of the Defense Industrial Base Consortium (DIBC), the company is well-positioned to secure Department of Defense (DoD) grants aimed at strengthening domestic critical mineral supply chains. With China’s recent export restrictions, Nova’s Estelle Project is strategically positioned to address the growing supply gap and reduce reliance on foreign sources. Financially, Nova is taking proactive steps to fund its exploration and development programs. In early 2025, the company sold its non-core investment in Snow Lake Resources for $6.73 million, using the proceeds to reduce debt and strengthen its balance sheet. Additionally, the exercise of NASDAQ warrants brought in $0.79 million, further bolstering the company’s cash position. With $16 million in cash and no debt, Nova is well-funded to advance its 2025 exploration program, which includes resource drilling at Stibium and other antimony prospects. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performances are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been compensated to assist in the production and distribution of this content by MILIF. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only; you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third-party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details Mark McKelvie +1 585-301-7700 Mark@razorpitch.com Company Website http://razorpitch.com

February 25, 2025 07:00 AM Eastern Standard Time

Article thumbnail News Release

Kadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its Type 1 Diabetes Treatment

NLS Pharmaceutics

NLS Pharmaceutics Ltd. (Nasdaq: NLSP”) (“NLS”) and Kadimastem Ltd. (“Kadimastem”), a clinical-stage company specializing in "off-the-shelf" allogeneic cell therapy products for neurodegenerative diseases and diabetes, in collaboration with iTolerance Inc. (“iTolerance”), a U.S. based regenerative medicine company, announced today the result from the Type B pre-IND meeting held by Kadimastem and iTolerance with a committee of the U.S Food and Drug Administration (“FDA”) on February 24, 2025, regarding the development of iTOL-102, a potential cure for diabetes that would not require life-long chronic immune system suppression. iTOL-102 is an investigational biologic for the treatment and potential cure of Type 1 Diabetes consisting of Kadimastem’s allogenic human stem cell-derived pancreatic islets (IsletRx cells) combined with iTolerance’s immunomodulator (iTOL-100). Kadimastem and iTolerance believe that the completion of the pre-IND meeting is a significant milestone toward the clinical development of iTOL-102, an on-going collaborative research initiative between iTolerance and Kadimastem, funded in part by grants received from the Israel-U.S. Binational Industrial Research and Development Foundation. iTOL-102 was evaluated at the fast-track center for testing at the Diabetes Research Institute (“DRI”) at the University of Miami School of Medicine, where it was designated as a potential breakthrough transplantation approach for the treatment of Type 1 Diabetes, as the novel combination of tolerance-inducing agent and human stem cell-derived islets. iTOL-102 demonstrated functional insulin release and disease reversal in an animal model, with full compatibility between IsletRx cells and iTOL-100. Prior to the meeting with the FDA, Kadimastem and iTolerance received a preliminary response document from the FDA, providing critical feedback on their current preclinical and clinical development plans. This guidance is instrumental in moving forward with the next stages of development. Based on the feedback provided at the pre-IND meeting, Kadimastem and iTolerance are now updating their plans for a safety toxicology study and the preparation of a First-in-Human clinical trial. Kadimastem believes its collaboration with iTolerance signifies a potentially transformative step in diabetes treatment, paving the way towards the potential development of iTOL-100 and requesting regulatory approvals for commercialization of a potential cure for type 1 diabetes. iTOL-100 is an immunomodulatory microgel technology being developed by iTolerance designed to reduce or eliminate the need for life-long chronic systemic immunosuppression following transplantation of allogenic cells. In a preclinical diabetic rodent model designed by iTolerance, iTOL-100 was shown by iTolerance to be compatible with Kadimastem’s IsletRx human stem cell-derived islets. Kadimastem’s IsletRx is a clinical-grade product candidate comprising human pancreatic islet-like cells capable of secreting insulin. IsletRx, a preparation of human stem cell-derived islets developed by Kadimastem, is a scalable and virtually unlimited source of insulin-producing cells which could address the critical shortage of donor islets for transplantation. This innovative therapy may effectively detect glucose levels in the body and produce the necessary amounts of insulin and glucagon. Dr. Anthony Japour, Chief Executive Officer of iTolerance, commented, “I believe that the feedback from the FDA is a critical milestone in the development of iTOL-102, and we are encouraged by their support for our innovative approach to treating Type 1 diabetes. We believe that the successful outcome of this meeting validates our commitment to bring a game-changing therapy to patients, one that could ultimately eliminate the need for chronic life-long immunosuppression. We look forward to continuing our collaboration with Kadimastem and working closely with the FDA.” Alex Zwyer, CEO of NLS, commented, “I believe that the news demonstrates the strength of the proposed merger of NLS and Kadimastem and its technology platform to build a healthy, strong merged company that will benefit shareholders.” Kadimastem Executive Chairman and CEO Ronen Twito said, "The promising results from the fast-track center for testing at the DRI, combined with the comprehensive studies conducted by iTolerance and Kadimastem, enabled us to complete this important milestone. We are working closely with the FDA on the necessary steps needed to implement this potential innovative technology for patients with Type 1 diabetes and demonstrate a novel islet cell transplantation approach with no need for immunosuppression.” About Kadimastem Kadimastem is a clinical stage cell therapy company, developing "off-the-shelf", allogeneic, proprietary cell products based on its technology platform for the expansion and differentiation of Human Embryonic Stem Cells (hESCs) into functional cells. AstroRx®, the company's lead product, is an astrocyte cell therapy in clinical development for the treatment for ALS and in pre-clinical studies for other neurodegenerative indications. IsletRx is the company's treatment for diabetes. IsletRx is comprised of functional pancreatic islet cells producing and releasing insulin and glucagon, intended to treat and potentially cure patients with insulin-dependent diabetes. Kadimastem was founded by Professor Michel Revel, Chief Scientific Officer of the company and Professor Emeritus of Molecular Genetics at the Weizmann Institute of Science. Professor Revel received the Israel Prize for the invention and development of Rebif®, a multiple sclerosis blockbuster drug sold worldwide. Kadimastem is traded on the Tel Aviv Stock Exchange (TASE: KDST). About iTolerance, Inc. iTolerance is a regenerative medicine company developing technologies to enable tissue, organoid or cell therapy without requiring life-long immunosuppression. Leveraging its proprietary biotechnology-derived Streptavidin-FasL fusion protein/biotin-PEG microgel (SA-FasL microgel) platform technology, iTOL-100, iTolerance is advancing a pipeline of programs using both allogenic cadaveric and stem cell-derived pancreatic islet to potentially cure Type 1 diabetes. Utilizing iTOL-100 to induce local immune tolerance, the Company is developing its lead indication as a potential cure for Type 1 Diabetes without the need for life-long immunosuppression. Additionally, the Company is developing iTOL-201 for treating liver failure by utilizing hepatocytes and iTOL-401 as a nanoparticle formulation for large organ transplants without the need for life-long immunosuppression. For more information, please visit itolerance.com. We are a clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system, or CNS, disorders, who have unmet medical needs. This press release contains expressed or implied forward-looking statements pursuant to U.S. Federal securities laws. For example, NLS and Kadimastem are using forward-looking statements when they discuss the belief that the results of the pre-IND meeting with the FDA demonstrates the strength of the proposed merger; that the meeting with the FDA is a significant milestone in the development of iTOL-102, and the expected benefits of iTOL-102 in the treatment of diabetes. These forward-looking statements and their implications are based on the current expectations of the management of NLS and Kadimastem and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: risks related to the companies’ ability to complete the merger on the proposed terms and schedule, including risks and uncertainties related to the satisfaction of the closing conditions related to the merger agreement and risks and uncertainties related to the failure to timely, or at all, obtain shareholder approvals for the transaction; unexpected costs, charges or expenses resulting from the transaction and potential adverse reactions or changes to business relationships resulting from the announcement or completion of the merger; changes in technology and market requirements; either or both companies may encounter delays or obstacles in launching and/or successfully completing their clinical trials; the companies’ products may not be approved by regulatory agencies; their technologies may not be validated as they progress and their methods may not be accepted by the scientific community; either of both of the companies may be unable to retain or attract key employees whose knowledge is essential to the development of their products; unforeseen scientific difficulties may develop with the products being advanced by the companies; their products may wind up being more expensive than anticipated; results in the laboratory may not translate to equally good results in real clinical settings; results of preclinical studies may not correlate with the results of human clinical trials; the companies’ patents may not be sufficient; their products may harm recipients; changes in legislation may adversely impact either or both of the companies; inability to timely develop and introduce new technologies, products and applications; and loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of candidate products to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, neither Kadimastem nor NLS undertakes any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting NLS is contained under the heading “Risk Factors” in NLS’s annual report on Form 20-F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”), which is available on the SEC’s website, www.sec.gov, and in subsequent filings made by NLS with the SEC, including under the heading “Risk Factors” in NLS’s registration statement on Form F-4, filed with the SEC on December 27, 2024. This press release may include forward-looking information as defined in the Securities Law, 5728 – 1968. Forward-looking information is uncertain and mostly is not under Kadimastem’s control and the realization or non-realization of forward-looking information will be affected, among other things, by the risk factors characterizing the company's activity, as well as developments in the general environment and external factors affecting the company's activity. The company's results and achievements in the future may differ materially from any presented herein and the company makes no undertaking to update or revise such projection or estimate and does not undertake to update this document. This press release does not constitute a proposal to purchase the company's securities or an invitation to receive such offers. Investment in securities in general and in the company in particular bears risks. One should consider that past performance does not necessarily indicate performance in the future. No Offer or Solicitation: This communication is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Additional Information about the Transaction and Where to Find ItIn connection with the proposed transaction, NLS has filed a Registration Statement on Form F-4, including a proxy statement/prospectus, with the SEC. NLS may also file other relevant documents with the SEC regarding the proposed transaction. This document is not a substitute for the proxy statement/prospectus or any other document that NLS may file with the SEC. The proxy statement (if and when available) will be mailed or delivered to shareholders of NLS and Kadimastem. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain free copies of the proxy statement/prospectus (if and when available) and other documents containing important information about NLS and Kadimastem and the proposed transaction, once such documents are filed with the SEC through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by the Company will be available free of charge on NLS’s website at www.nlspharma.com. Participants in the Solicitation: NLS, Kadimastem, and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from NLS and Kadimastem shareholders in respect of the proposed transaction. Information about the directors and executive officers of NLS, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in NLS’s Annual Report on Form 20-F for the fiscal year ended December 31, 2023, which was filed with the SEC on May 15, 2024. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed merger when such materials become available. Investors should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from NLS Pharmaceutics using the sources indicated above. Contact Details NLS Pharmaceutics Ltd. NLS Pharmaceutics Ltd. +41 44 512 21 50 contact@nls-pharma.com Kadimastem Ltd. Sarah Bazak +972 73-797-1615 s.bazak@kadimastem.com Company Website https://nlspharmaceutics.com/

February 25, 2025 07:00 AM Eastern Standard Time

Image
Article thumbnail News Release

Robertson Stephens Launches Family Office for Select Clients

Robertson Stephens

Robertson Stephens today announced that it has hired Bruce Stewart to launch a family office that will serve select ultra-high-net-worth clients who have outgrown a multi-family office platform but are not ready to transition to a pure single-family office environment. As Head of Family Office at Robertson Stephens, Stewart brings over 25 years of experience in building and advising single-family offices, as well as serving as an outsourced chief investment officer. In this role, he will develop a practice designed for families with more sophisticated needs than those typically addressed by traditional multi-family offices. “We have always planned to have a family office service offering adjacent to our wealth management practice,” said Raj Bhattacharyya, Chief Executive Officer of Robertson Stephens. “With the launch of our family office, clients have the rare opportunity to access unique and highly valuable services beyond the standard offering seen in traditional private banks, multi-family offices and many other players in the industry without the upfront and high recurring expenses typical of a single-family office. Bruce is not only a deep expert in this space, he has also demonstrated his ability to build out successful single-family offices over the past few years.” Before Robertson Stephens, Stewart was the founder and Managing Partner of Spartan Risk Solutions (SRS), a discreet family-office consultancy specializing in the development of family offices and outsourced chief investment officer solutions. In this role, Stewart built and managed $23 billion in wealth for four families. Previously, Stewart was the global head of investments for Bank of New York Family Office, where he led an investment team managing nearly $15 billion in assets. His other leadership roles include having served as President of BNY Mellon Canada and co-head of investments at Toronto Dominion Bank. “I’m grateful to Robertson Stephens for this opportunity to build out this first-of-its-kind service,” Stewart said. "In my experience, some families have outgrown the capabilities of a traditional multi-family office but prefer to avoid the financial commitment of establishing their own. These families have more complex needs that require a specialized skill set, enhanced capabilities, and a sophisticated approach. I’m excited to build this practice at Robertson Stephens and deliver a truly differentiated solution." Contact Details Peter Page ppage@vocatusllc.com Company Website https://rscapital.com/

February 24, 2025 12:33 PM Eastern Standard Time

1 ... 2930313233 ... 3862